Global CRISPR Technology Market by Product Type (Product, Software and Service), By Application (Biomedical, Agricultural), By End-User (Pharma & Biopharma Companies, Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2032

Market.us announces publication of its most recently generated research report titled, “Global CRISPR Technology Market by Product Type  (Enzymes, Kits & Reagents, gRNA, and Design Tools), By Application (Biomedical and Agricultural), By End-User (Pharma & Biopharma Companies, Biotechnology Companies, Academic & Research Institutes, and Contract Research Organizations) and By Region (North America, Europe, Asia-Pacific, South America, and MEA) which offers a holistic view of the Global CRISPR Technology Market through systematic segmentation that covers every aspect of the target market.

Global CRISPR Technology Market is expected to grow from USD 562 million in 2018 to USD 1,715 million by 2023, at a CAGR of 25%.

CRISPR technology is a powerful genome editing tool that belongs to the DNA sequence family. CRISPR stands for clusters of regularly spaced short palindromic repeats. It is found in the genomics of prokaryotes such as bacteria and archaea. CRISPR is a technology that allows researchers to easily alter DNA sequences and alter gene function.

Preventing disease transmission and curing diseases, correcting genetic defects, and improving crops are some of the potential applications of CRISPR technology. The technology follows a process that includes the insertion, deletion, or alteration of biological DNA with the help of engineered nucleases and molecular mechanisms.

The emergence of CRISPR technology has changed the field of genome editing and paved the way for the development of a variety of gene therapies, which are used to treat numerous genetic diseases.

Global CRISPR Technology Market Revenue (US$ Mn), 2019–2029

The rapid growth in the adoption of CRISPR technology in pet breeding, non-allergenic food, DNA’tape recorders’, more environmentally friendly fuels, pest elimination, faster horse racing and other applications are some of the main factors driving the development of global CRISPR technology markets.

The ongoing COVID-19 pandemic has adversely affected all walks of life around the world. The coronavirus pandemic may affect multiple stages of clinical trials. This is because many people involved in these clinical trials have coronavirus. This factor is expected to hinder the growth of the global CRISPR technology market to a large extent.

The elderly are more prone to various diseases, which increases the demand for better treatment options. The growing demand for drug discovery has largely driven the growth of the CRISPR technology market. This factor may create a large number of incremental opportunities for the growth of the CRISPR technology market.

Global CRISPR Technology Market Attractiveness Analysis by Product Type, 2014–2030

The global CRISPR technology market is segmented based on product type, application, end-user, and regions. Based on product type, the market is segmented into enzymes, kits & reagents, gRNA, and design tools. Based on the application, the market is segmented into biomedical and agricultural. Based on end-use, the market is segmented into pharma & biopharma companies, biotechnology companies, academic & research institutes, and contract research organizations.

Among the product type, the kits & reagents segment is expected to register higher growth during the forecast period. Among the application, the agriculture segment is expected to register a relatively higher revenue growth over the forecast period. Among the end-user, the academic & research institutes segment is expected to register a relatively higher CAGR over the forecast period.

Based on the region, North America is expected to gain a high market revenue share, followed by the European region owing to advanced R&D infrastructure and increased investments for research activities in the regions. The Asia Pacific region is projected to show noteworthy CAGR growth. The majority of Asian countries depend on agriculture. The incidence rate of genetic disorders and infertility is also growing in the region.

Hence, the opportunity for CRISPR technology in this region is expected to show remarkable growth. The Middle East & Africa and South America region are expected to show moderate revenue.

The research report on the Global CRISPR Technology Market includes profiles of some of the major companies such as Thermo Fisher Scientific Inc, Merck KGaA, Integrated DNA Technologies (Danaher Corporation), Agilent Technologies, Inc., Genscript Biotech Corp, New England Biolabs Inc., Horizon Discovery Group Plc, Cellecta Limited, GeneCopoeia Inc., Origene Technologies Inc., and others.

Segmentation for Global CRISPR Technology Market, based on Product Type, Application, End-Use and Regions:

Based on Product Type:

• Products
• Services

Based on Application:

• Biomedical Applications
• Agricultural Applications
• Industrial Applications
• Biological Research

Based on End User:

• Pharma & Biopharma Companies
• Biotechnology Companies
• Academic & Research Institutes
• Contract Research Organizations

Based on Key Players:

• Thermo Fisher Scientific Inc
• Merck KGaA
• Integrated DNA Technologies (Danaher Corporation)
• Agilent Technologies Inc.
• Genscript Biotech Corp
• New England Biolabs Inc.
• Horizon Discovery Group Plc
• Cellecta Limited
• GeneCopoeia Inc.
• Origene Technologies Inc.
• others

Based on Regions:

• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa

For the CRISPR Gene Editing Market research study, the following years have been considered to estimate the market size: